Table 2.
Health care domain | IT dimension | Quality measure | pa | ra | R2 |
---|---|---|---|---|---|
Resident care | IT capabilities | Low-risk LS bowel or bladder incontinence | .01 | .14 | .02 |
LS with a urinary tract infection | .00 | −.19 | .03 | ||
LS assessed/given seasonal flu vaccine | .03 | −.15 | .02 | ||
Extent of IT use | High-risk LS with pressure ulcers | .00 | −.18 | .03 | |
Low-risk LS bowel or bladder incontinence | .00 | .19 | .04 | ||
LS with a urinary tract infection | .02 | −.14 | .02 | ||
SS with new or worsened pressure ulcers | .00 | −.16 | .02 | ||
SS newly received an antipsychotic medication | .05 | −.15 | .02 | ||
IT integration | Low-risk LS bowel or bladder incontinence | .00 | .20 | .04 | |
Clinical support | IT capabilities | SS who report moderate to severe pain | .00 | −.18 | .03 |
Extent of IT use | LS who report moderate to severe pain | .00 | −.16 | .03 | |
Integration | LS received antianxiety/hypnotic medication | .00 | −.17 | .03 | |
Administrative activities | IT capabilities | Low-risk LS bowel or bladder incontinence | .00 | .20 | .04 |
IT integration | LS worsened ability to move independently | .01 | .16 | .03 | |
LS received antianxiety/hypnotic medication | .01 | −.16 | .03 | ||
Total IT | Low-risk LS bowel or bladder incontinence | .03 | .15 | .02 | |
LS with a urinary tract infection | .01 | −.15 | .02 | ||
LS received antianxiety/hypnotic medication | .01 | −.15 | .02 |
Note. IT = information technology; LS = long-stay residents; SS = short-stay residents.
Only values with p value of .05 or less are shown in the table; other values with nonsignificant p values are not shown.